Royal Harbor Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Royal Harbor Partners's LLY Position: Q3 2026 in Review
Royal Harbor Partners reduced its Eli Lilly (LLY) stake by 2.1% in Q3 2026, selling an estimated $11.8K and leaving 463 shares worth $536K. The position accounts for 0.16% of the portfolio, ranked #38.
Royal Harbor Partners first reported a position in LLY in Q2 2020 and has held it in 23 quarters since. The position peaked at $2.08M in Q2 2022. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Royal Harbor Partners held 463 shares of Eli Lilly worth $536K as of Q3 2026.
- Royal Harbor Partners sold 10 Eli Lilly shares in Q3 2026, an estimated $11.8K.
- Eli Lilly made up 0.16% of Royal Harbor Partners's portfolio in Q3 2026, its #38 holding.
- Royal Harbor Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 23 quarters since.
- Royal Harbor Partners's Eli Lilly position peaked at $2.08M in Q2 2022.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Royal Harbor Partners's 13F filing for Q3 2026, filed 29 Oct 2026.